JUBEREQ 120 mg/1.7 ml sol inj 120 mg 1 pce

7680700940016 CH-70094 M05BX04 07.16.1.

Active substances:

Denosumabum

No images available

Details

Product number
7009401
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
denosumabum 120 mg, polysorbatum 20, sorbitolum 78.2 mg, acidum aceticum glaciale, natrii hydroxidum q.s. ad pH, aqua ad iniectabile q.s. ad solutionem pro 1.7 ml.

Articles (1)

Jubereq 120 mg/1.7 ml, Injektionslösung
Injektionslösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
20/05/2026
Professional SmPC
Français
20/05/2026
Professional SmPC
Italien
20/05/2026

Detailed composition

Substance Quantity Type Category
denosumabum
120.0 MG Substance Wirkstoff (Principe actif)
polysorbatum 20
- Substance HNIDK
sorbitolum
78.2 MG Substance HBESI
acidum aceticum glaciale
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 210.45
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/07/2026

Authorization holder

Accord Healthcare AG

4103 Bottmingen

Authorization information

Swissmedic authorization number
70094
Drug name
Jubereq, Injektionslösung
Galenic form
LSINJ
ATC Code
M05BX04
Authorization status
Z
Dispensation category
A
First authorization
29/04/2026
Authorization expiration date
28/04/2031
IT number
07.16.1.
Domain
Human medicine
Field of application
Knochenmetastasen solider Tumoren; Riesenzelltumoren des Knochens

Packaging details

Description (FR)
JUBEREQ 120 mg/1.7 ml sol inj 120 mg 1 pce
Description (DE)
JUBEREQ 120 mg/1.7 ml Inj Lös 120 mg 1 Stk
Market launch
05/06/2026
Narcotic (BTM)
No
Buy us a coffee Explore the data